Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
BMC Geriatrics
Published in: BMC Geriatrics 1/2023

Open Access 01-12-2023 | Research

Association of cardiovascular health at old age with all-cause mortality: a prospective cohort study in China

Authors: Shimin Chen, Haowei Li, Shengshu Wang, Shanshan Yang, Shaohua Liu, Yang Song, Xuehang Li, Rongrong Li, Jianhua Wang, Miao Liu, Yao He

Published in: BMC Geriatrics | Issue 1/2023

Login to get access

Abstract

Background

Cardiovascular disease has become the leading cause of death worldwide, but there is a lack of data on whether cardiovascular health (CVH) is associated with elderly mortality in China. We investigated the relationship between the ideal CVH score of Chinese elderly and the all-cause mortality.

Methods

The Beijing Elderly Comprehensive Health Cohort Study included a total of 4,499 participants aged 60 years and above. The CVH metric was calculated at baseline and had a score ranging from 0 to 12. The relationship of CVH metrics with all-cause mortality was investigated using Cox proportional hazard regression analysis. The robustness of results was tested using subgroup and sensitivity analysis.

Results

The median CVH score among participants was 8.00 (2.00), with only 8.0% scoring 11–12 points. 667 deaths were observed during an average follow-up time of 8.2 years. Participants with a CVH score of 11–12 had a decreased risk of all-cause mortality when compared to those with a CVH score of 0–4(HR = 0.584, 95% CI: 0.373–0.913). Participants had a 7.5% lower risk of all-cause death with each unit higher CVH score (HR = 0.925, 95%CI: 0.885–0.967) with a linearly decreasing trend (P nonlinear = 0.575). The relationships were greater in younger elderly people and stroke patients (P interaction = 0.011 and 0.037. respectively). The consistency of significant trends in sensitivity analysis shows the robustness of association (P trend < 0.001).

Conclusions

Among the Chinese elderly, there was a linear relationship between improving CVH scores and a lower risk of all-cause mortality. Because of the enormous benefits brought by one point, strategies are essential for improving cardiovascular health attainment.

Trial registration

This study was registered at China Clinical Trial Registration Center (ChiCTR2100049866).
Appendix
Available only for authorised users
Literature
1.
Mensah GA, Roth GA, Fuster V. The global burden of cardiovascular diseases and risk factors: 2020 and beyond. J Am Coll Cardiol. 2019;74(20):2529–32.PubMedCrossRef
2.
Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 Study. J Am Coll Cardiol. 2020;76(25):2982–3021.PubMedPubMedCentralCrossRef
3.
Figtree GA, Broadfoot K, Casadei B, Califf R, Crea F, Drummond GR, Freedman JE, Guzik TJ, Harrison D, Hausenloy DJ, et al. A call to action for new global approaches to cardiovascular disease drug solutions. Eur Heart J. 2021;42(15):1464–75.PubMedCrossRef
4.
Li X, Wu C, Lu J, Chen B, Li Y, Yang Y, Hu S, Li J. Cardiovascular risk factors in China: a nationwide population-based cohort study. Lancet Public Health. 2020;5(12):e672–81.PubMedCrossRef
5.
Liu S, Li Y, Zeng X, Wang H, Yin P, Wang L, Liu Y, Liu J, Qi J, Ran S, et al. Burden of cardiovascular diseases in China, 1990–2016: findings from the 2016 global burden of disease study. JAMA Cardiol. 2019;4(4):342–52.PubMedPubMedCentralCrossRef
6.
Feng Z, Glinskaya E, Chen H, Gong S, Qiu Y, Xu J, Yip W. Long-term care system for older adults in China: policy landscape, challenges, and future prospects. Lancet. 2020;396(10259):1362–72.PubMedCrossRef
7.
Zhao D, Liu J, Wang M, Zhang X, Zhou M. Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol. 2019;16(4):203–12.PubMedCrossRef
8.
Moran A, Gu D, Zhao D, Coxson P, Wang YC, Chen CS, Liu J, Cheng J, Bibbins-Domingo K, Shen YM, et al. Future cardiovascular disease in china: markov model and risk factor scenario projections from the coronary heart disease policy model-china. Circ Cardiovasc Qual Outcomes. 2010;3(3):243–52.PubMedPubMedCentralCrossRef
9.
Moran A, Zhao D, Gu D, Coxson P, Chen CS, Cheng J, Liu J, He J, Goldman L. The future impact of population growth and aging on coronary heart disease in China: projections from the coronary heart disease policy model-China. BMC Public Health. 2008;8:394.PubMedPubMedCentralCrossRef
10.
Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W, Li X, Wang L, Wang L, Liu Y, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2019;394(10204):1145–58.PubMedPubMedCentralCrossRef
11.
Zhang M, Shi Y, Shi O, Zhao Z, Zhang X, Li C, Huang Z, Zhao L, Wang L, Li Y, et al. Geographical variations in cardiovascular health in China: a nationwide population-based survey of 74,726 adults. Lancet Reg Health West Pac. 2020;3:100033.PubMedPubMedCentralCrossRef
12.
Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, Greenlund K, Daniels S, Nichol G, Tomaselli GF, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American heart association’s strategic impact goal through 2020 and beyond. Circulation. 2010;121(4):586–613.PubMedCrossRef
13.
Yang Q, Cogswell ME, Flanders WD, Hong Y, Zhang Z, Loustalot F, Gillespie C, Merritt R, Hu FB. Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults. JAMA. 2012;307(12):1273–83.PubMedPubMedCentralCrossRef
14.
Shah AM, Claggett B, Folsom AR, Lutsey PL, Ballantyne CM, Heiss G, Solomon SD. Ideal cardiovascular health during adult life and cardiovascular structure and function among the elderly. Circulation. 2015;132(21):1979–89.PubMedPubMedCentralCrossRef
15.
Shay CM, Gooding HS, Murillo R, Foraker R. Understanding and improving cardiovascular health: an update on the American heart association’s concept of cardiovascular health. Prog Cardiovasc Dis. 2015;58(1):41–9.PubMedCrossRef
16.
Younus A, Aneni EC, Spatz ES, Osondu CU, Roberson L, Ogunmoroti O, Malik R, Ali SS, Aziz M, Feldman T, et al. A systematic review of the prevalence and outcomes of ideal cardiovascular health in US and non-US populations. Mayo Clin Proc. 2016;91(5):649–70.PubMedCrossRef
17.
Sabia S, Fayosse A, Dumurgier J, Schnitzler A, Empana JP, Ebmeier KP, Dugravot A, Kivimäki M, Singh-Manoux A. Association of ideal cardiovascular health at age 50 with incidence of dementia: 25 year follow-up of Whitehall II cohort study. BMJ. 2019;366:l4414.PubMedPubMedCentralCrossRef
18.
Foraker RE, Benziger CP, DeBarmore BM, Cené CW, Loustalot F, Khan Y, Anderson CAM, Roger VL. Achieving optimal population cardiovascular health requires an interdisciplinary team and a learning healthcare system: a scientific statement from the American heart association. Circulation. 2021;143(2):e9–18.PubMedCrossRef
19.
van Sloten TT, Tafflet M, Périer MC, Dugravot A, Climie RED, Singh-Manoux A, Empana JP. Association of change in cardiovascular risk factors with incident cardiovascular events. JAMA. 2018;320(17):1793–804.PubMedPubMedCentralCrossRef
20.
Wang T, Lu J, Su Q, Chen Y, Bi Y, Mu Y, Chen L, Hu R, Tang X, Yu X, et al. ideal cardiovascular health metrics and major cardiovascular events in patients with prediabetes and diabetes. JAMA Cardiol. 2019;4(9):874–83.PubMedPubMedCentralCrossRef
21.
Perak AM, Ning H, Khan SS, Bundy JD, Allen NB, Lewis CE, Jacobs DR Jr, Van Horn LV, Lloyd-Jones DM. Associations of late adolescent or young adult cardiovascular health with premature cardiovascular disease and mortality. J Am Coll Cardiol. 2020;76(23):2695–707.PubMedPubMedCentralCrossRef
22.
Rasmussen-Torvik LJ, Shay CM, Abramson JG, Friedrich CA, Nettleton JA, Prizment AE, Folsom AR. Ideal cardiovascular health is inversely associated with incident cancer: the atherosclerosis risk in communities study. Circulation. 2013;127(12):1270–5.PubMedPubMedCentralCrossRef
23.
Lau ES, Paniagua SM, Liu E, Jovani M, Li SX, Takvorian K, Suthahar N, Cheng S, Splansky GL, Januzzi JL Jr, et al. Cardiovascular risk factors are associated with future cancer. JACC CardioOncol. 2021;3(1):48–58.PubMedPubMedCentralCrossRef
24.
González HM, Tarraf W, Harrison K, Windham BG, Tingle J, Alonso A, Griswold M, Heiss G, Knopman D, Mosley TH. Midlife cardiovascular health and 20-year cognitive decline: atherosclerosis risk in communities study results. Alzheimers Dement. 2018;14(5):579–89.PubMedCrossRef
25.
Samieri C, Perier MC, Gaye B, Proust-Lima C, Helmer C, Dartigues JF, Berr C, Tzourio C, Empana JP. Association of cardiovascular health level in older age with cognitive decline and incident dementia. JAMA. 2018;320(7):657–64.PubMedPubMedCentralCrossRef
26.
Speh A, Wang R, Winblad B, Kramberger MG, Bäckman L, Qiu C, Laukka EJ. The relationship between cardiovascular health and rate of cognitive decline in young-old and old-old adults: a population-based study. J Alzheimers Dis. 2021;84(4):1523–37.PubMedPubMedCentralCrossRef
27.
Aneni EC, Crippa A, Osondu CU, Valero-Elizondo J, Younus A, Nasir K, Veledar E. Estimates of mortality benefit from ideal cardiovascular health metrics: a dose response meta-analysis. J Am Heart Assoc. 2017;6(12):e006904.PubMedPubMedCentralCrossRef
28.
Fang N, Jiang M, Fan Y. Ideal cardiovascular health metrics and risk of cardiovascular disease or mortality: a meta-analysis. Int J Cardiol. 2016;214:279–83.PubMedCrossRef
29.
Corlin L, Short MI, Vasan RS, Xanthakis V. Association of the duration of ideal cardiovascular health through adulthood with cardiometabolic outcomes and mortality in the framingham offspring study. JAMA Cardiol. 2020;5(5):549–56.PubMedCrossRef
30.
Gao B, Wang F, Zhu M, Wang J, Zhou M, Zhang L, Zhao M. Cardiovascular health metrics and all-cause mortality and mortality from major non-communicable chronic diseases among Chinese adult population. Int J Cardiol. 2020;313:123–8.PubMedCrossRef
31.
Dong Y, Hao G, Wang Z, Wang X, Chen Z, Zhang L. Ideal Cardiovascular health status and risk of cardiovascular disease or all-cause mortality in chinese middle-aged population. Angiology. 2019;70(6):523–9.PubMedCrossRef
32.
Zhou L, Zhao L, Wu Y, Wu Y, Gao X, Li Y, Mai J, Nie Z, Ou Y, Guo M, et al. Ideal cardiovascular health metrics and its association with 20-year cardiovascular morbidity and mortality in a Chinese population. J Epidemiol Community Health. 2018;72(8):752–8.PubMedCrossRef
33.
Guo L, Zhang S. Association between ideal cardiovascular health metrics and risk of cardiovascular events or mortality: a meta-analysis of prospective studies. Clin Cardiol. 2017;40(12):1339–46.PubMedPubMedCentralCrossRef
34.
Yang PS, Jang E, Yu HT, Kim TH, Pak HN, Lee MH, Joung B. Changes in cardiovascular risk factors and cardiovascular events in the elderly population. J Am Heart Assoc. 2021;10(11):e019482.PubMedPubMedCentralCrossRef
35.
Han X, Jiang Z, Li Y, Wang Y, Liang Y, Dong Y, Tang S, Du Y, Qiu C. Sex disparities in cardiovascular health metrics among rural-dwelling older adults in China: a population-based study. BMC Geriatr. 2021;21(1):158.PubMedPubMedCentralCrossRef
36.
Gaye B, Canonico M, Perier MC, Samieri C, Berr C, Dartigues JF, Tzourio C, Elbaz A, Empana JP. Ideal cardiovascular health, mortality, and vascular events in elderly subjects: the three-city study. J Am Coll Cardiol. 2017;69(25):3015–26.PubMedCrossRef
37.
Ahmed A, Pinto Pereira SM, Lennon L, Papacosta O, Whincup P, Wannamethee G. Cardiovascular health and stroke in older British men: prospective findings from the British regional heart study. Stroke. 2020;51(11):3286–94.PubMedCrossRef
38.
Deng Y, Gao Q, Yang D, Hua H, Wang N, Ou F, Liu R, Wu B, Liu Y. Association between biomass fuel use and risk of hypertension among Chinese older people: a cohort study. Environ Int. 2020;138:105620.PubMedCrossRef
39.
Neal B, Wu Y, Feng X, Zhang R, Zhang Y, Shi J, Zhang J, Tian M, Huang L, Li Z, et al. Effect of salt substitution on cardiovascular events and death. N Engl J Med. 2021;385(12):1067–77.PubMedCrossRef
40.
Han C, Liu F, Yang X, Chen J, Li J, Cao J, Li Y, Shen C, Yu L, Liu Z, et al. Ideal cardiovascular health and incidence of atherosclerotic cardiovascular disease among Chinese adults: the China-PAR project. Sci China Life Sci. 2018;61(5):504–14.PubMedCrossRef
41.
Lu J, Lu Y, Wang X, Li X, Linderman GC, Wu C, Cheng X, Mu L, Zhang H, Liu J, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project). Lancet. 2017;390(10112):2549–58.PubMedCrossRef
42.
Bi Y, Jiang Y, He J, Xu Y, Wang L, Xu M, Zhang M, Li Y, Wang T, Dai M, et al. Status of cardiovascular health in Chinese adults. J Am Coll Cardiol. 2015;65(10):1013–25.PubMedCrossRef
43.
Sanghavi M, Gulati M. Sex differences in the pathophysiology, treatment, and outcomes in IHD. Curr Atheroscler Rep. 2015;17(6):511.PubMedCrossRef
44.
Liu M, Kou F, Yang S, Wang S, He Y, Zhang W. Ideal cardiovascular health in the oldest-old and centenarians and its association with disability and health-related quality of life. Front Cardiovasc Med. 2021;8:603877.PubMedPubMedCentralCrossRef
45.
Yu Y, Dong Z, Li Y, Zhang J, Yin S, Gao X, Wu S. The cardiovascular and cerebrovascular health in North China from 2006 to 2011: results from the KaiLuan study. Front Cardiovasc Med. 2021;8:683416.PubMedPubMedCentralCrossRef
46.
MI N, Kunutsor SK, Voutilainen A, Kurl S, Kauhanen J, AL J. Association between ideal cardiovascular health and risk of sudden cardiac death and all-cause mortality among middle-aged men in Finland. Eur J Prev Cardiol. 2021;28(3):294–300.CrossRef
47.
Isiozor NM, Kunutsor SK, Voutilainen A, Kurl S, Kauhanen J, Laukkanen JA. American heart association’s cardiovascular health metrics and risk of cardiovascular disease mortality among a middle-aged male Scandinavian population. Ann Med. 2019;51(5–6):306–13.PubMedPubMedCentralCrossRef
48.
Han L, You D, Ma W, Astell-Burt T, Feng X, Duan S, Qi L. National trends in American heart association revised life’s simple 7 metrics associated with risk of mortality among US adults. JAMA Netw Open. 2019;2(10):e1913131.PubMedPubMedCentralCrossRef
49.
van Oort S, Beulens JWJ, van Ballegooijen AJ, Burgess S, Larsson SC. Cardiovascular risk factors and lifestyle behaviours in relation to longevity: a Mendelian randomization study. J Intern Med. 2021;289(2):232–43.PubMedCrossRef
Metadata
Title
Association of cardiovascular health at old age with all-cause mortality: a prospective cohort study in China
Authors
Shimin Chen
Haowei Li
Shengshu Wang
Shanshan Yang
Shaohua Liu
Yang Song
Xuehang Li
Rongrong Li
Jianhua Wang
Miao Liu
Yao He
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2023
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-023-04093-9

Other articles of this Issue 1/2023

BMC Geriatrics 1/2023 Go to the issue

Research

The prevalence of eHealth literacy and its relationship with perceived health status and psychological distress during Covid-19: a cross-sectional study of older adults in Blekinge, Sweden

Research

Attitudes and knowledge of nurses working at night and sleep promotion in nursing home residents: multicenter cross-sectional survey

Research

Association of laxatives use with incident dementia and modifying effect of genetic susceptibility: a population-based cohort study with propensity score matching

Research

The effect of research on life satisfaction in middle-aged and older adults: physical disability and physical activity as a parallel and serial mediation analysis

Research

Breaking ground: nursing-led approach to alleviating constipation in Parkinson’s disease

Research

How do individual, social, environmental, and resilience factors shape self-reported health among community-dwelling older adults: a qualitative case study
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits